HLA-DR4 and pulmonary dysfunction in rheumatoid arthritis

Area of Science:

• Immunogenetics
• Rheumatology
• Pulmonology

Background:

• Rheumatoid arthritis (RA) is linked to increased HLA-DR4 antigen frequency.
• Preliminary studies suggest HLA-DR4 may influence obstructive lung disease in RA patients.

Purpose of the Study:

• To prospectively assess the impact of HLA-DR4 on pulmonary function in rheumatoid arthritis.
• To investigate the relationship between HLA-DR4, smoking, and lung disease in RA.

Main Methods:

• Pulmonary function tests were conducted on four groups of RA patients stratified by HLA-DR4 status and smoking history.
• Subjects included DR4-positive smokers, DR4-negative smokers, DR4-positive non-smokers, and DR4-negative non-smokers.
• Lung function parameters like FEV1 and FVC were measured.

Main Results:

• DR4-positive RA patients showed significantly reduced FEV1 and FVC compared to DR4-negative patients, irrespective of smoking.
• Patients with secondary Sjögren's syndrome exhibited significant reductions in FEV1, FVC, and the FEV1/FVC ratio.

Conclusions:

• The presence of the HLA-DR4 antigen is associated with abnormal pulmonary function in rheumatoid arthritis.
• Secondary Sjögren's syndrome is also a significant factor associated with impaired lung function in RA patients.
• These findings emphasize the role of specific genetic markers and autoimmune comorbidities in RA-related lung disease.